Tags: Drug.

Nintedanib (formerly BIBF 1120; trade name Vargatef) is a small molecule of angiokinase inhibitor class inhibiting vascular endothelial growth factor receptor (VEGFR) fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR) being developed by Boehringer Ingelheim for use as an anti-vascular anti-cancer agent.

Intedanib.svg
CAS number
656247-17-5
FDA UNII code
G6HRD2P839
IUPAC name
methyl (3Z)-3-[(4-methyl[(4-methylpiperazin-1-yl)acetyl]aminophenyl)amino](phenyl)methylidene-2-oxo-23-dihydro-1H-indole-6-carboxylate

Loading...

This page contains content from the copyrighted Wikipedia article "Nintedanib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.